前隐静脉:第一部分——美国静脉与淋巴学会、美国静脉论坛及国际静脉病学联盟共同认可的立场声明
美国静脉与淋巴学会、国际静脉病学联盟及美国静脉论坛组建多学会专家组,审查关于「前副隐静脉」的解剖与临床文献。专家组认为「副」字暗示浅表属支,但证据支持其与大隐静脉和小隐静脉类似属于主干静脉,建议将术语改为「前隐静脉」。
要点
- 「前副隐静脉」的术语不清晰可能影响治疗结局。
- 证据支持前副隐静脉为与大隐静脉、小隐静脉类似的主干静脉。
- 专家组建议将「前副隐静脉」改称为「前隐静脉」。
核心结论
- 专家组建议将「前副隐静脉」(AASV)改称为「前隐静脉」(ASV)。
研究设计与样本
- 由美国静脉与淋巴学会、国际静脉病学联盟及美国静脉论坛组建的多学会专家组,审查关于「前副隐静脉」术语的现有解剖与临床文献。
主要发现
- 使用「副」字暗示该静脉为浅表属支,但证据支持其作为主干静脉的作用与大隐静脉和小隐静脉相似。
关键数值与推荐
- 专家组建议将「前副隐静脉」(AASV)改称为「前隐静脉」(ASV)。
临床怎么用
- 专家组建议更改术语,将「前副隐静脉」(AASV)改称为「前隐静脉」(ASV)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a lack of clarity regarding the terminology of the anterior accessory saphenous vein (AASV) that can impact treatment outcomes. Although use of the word "accessory" implies that the vein is a superficial tributary, evidence supports its role as a truncal vein, similar to the great and small saphenous veins, and warranting a change in terminology. METHODS: A multisocietal panel was convened by the American Vein and Lymphatic Society (AVLS), the Union International of Phlebology (UIP), and the American Venous Forum (AVF). The group was charged with reviewing the existing anatomic and clinical literature pertaining to the term "anterior accessory saphenous vein" and to consider the need for alternative terminology. CONCLUSIONS: Based on the insights gathered from the literature review and extensive discussions, the panel recommends changing the terminology such that the "anterior accessory saphenous vein" (AASV) now be designated the anterior saphenous vein (ASV).
引用
- Meissner M, Boyle EM, Labropoulos N, et al. The anterior saphenous vein. Part 1. A position statement endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 38008181. doi:10.1016/j.jvsv.2023.101721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。